Real-world outcomes in pancreatic adenocarcinoma (PDAC) and persona types with implications for standard of care (SOC) therapy (Tx).

Emanuel  Petricoin

Leadership - Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Perthera; Perthera; Perthera; Perthera

Stock and Other Ownership Interests  - Avant Diagnostics; Avant Diagnostics; Avant Diagnostics; Avant Diagnostics; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Perthera; Perthera; Perthera; Perthera

Consulting or Advisory Role - Avant Diagnostics; Avant Diagnostics; Avant Diagnostics; Avant Diagnostics; AZGen; AZGen; AZGen; AZGen; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Perthera; Perthera; Perthera; Perthera

Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Ceres Nanosciences (Inst); Ceres Nanosciences (Inst); Ceres Nanosciences (Inst); Ceres Nanosciences (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst); Mirati Therapeutics (Inst)

Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; NIH Patents Licensing Fee Distribution/Royalty; NIH Patents Licensing Fee Distribution/Royalty; NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty; University assigned patent licensing fee/royalty; University assigned patent licensing fee/royalty; University assigned patent licensing fee/royalty

Travel, Accommodations, Expenses - Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Ceres Nanosciences; Perthera; Perthera; Perthera; Perthera

Michael J.  Pishvaian

Stock and Other Ownership Interests  - Perthera; Perthera; Perthera; Perthera

Honoraria - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical

Consulting or Advisory Role - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Ignyta; Ignyta; Ignyta; Ignyta; Merck; Merck; Merck; Merck; Perthera; Perthera; Perthera; Perthera; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; RenovoRx; RenovoRx; RenovoRx; RenovoRx; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical

Research Funding - ARMO BioSciences (Inst); ARMO BioSciences (Inst); ARMO BioSciences (Inst); ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bavarian Nordic (Inst); Bavarian Nordic (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celldex (Inst); Celldex (Inst); Celldex (Inst); Celldex (Inst); Curegenix (Inst); Curegenix (Inst); Curegenix (Inst); Curegenix (Inst); FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)

Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Perthera patient matching algorithm; Perthera patient matching algorithm; Perthera patient matching algorithm

Travel, Accommodations, Expenses - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Merck; Merck; Merck; Merck; Perthera; Perthera; Perthera; Perthera; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical

Patricia  DeArbeloa

No Relationships to Disclose

Daniel  Barg

Employment - Perthera; Perthera; Perthera; Perthera

Dzung  Thach

Employment - Perthera; Perthera; Perthera; Perthera

Jonathan Robert  Brody

Stock and Other Ownership Interests  - Perthera; Perthera; Perthera; Perthera

Consulting or Advisory Role - Perthera; Perthera; Perthera; Perthera

Travel, Accommodations, Expenses - Perthera; Perthera; Perthera; Perthera

Lynn McCormick  Matrisian

No Relationships to Disclose

Vincent  Chung

Consulting or Advisory Role - Apeiron Biologics; Apeiron Biologics; Apeiron Biologics; Apeiron Biologics; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Ipsen; Ipsen; Ipsen; Ipsen; Perthera; Perthera; Perthera; Perthera; Westwood Bioscience; Westwood Bioscience; Westwood Bioscience; Westwood Bioscience

Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen

Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)

Andrew Eugene  Hendifar

Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Perthera; Perthera; Perthera; Perthera

Research Funding - Ipsen; Ipsen; Ipsen; Ipsen

Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme

Sameh  Mikhail

Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Perthera; Perthera; Perthera; Perthera

Davendra  Sohal

Honoraria - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine

Consulting or Advisory Role - Ability Pharma; Ability Pharma; Ability Pharma; Ability Pharma; Perthera; Perthera; Perthera; Perthera

Research Funding - Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst)

Edik Matthew  Blais

Employment - AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); Perthera; Perthera; Perthera; Perthera

Stock and Other Ownership Interests  - Perthera; Perthera; Perthera; Perthera

Patents, Royalties, Other Intellectual Property - Named as an inventor on patents filed by Perthera, Inc. (as an employee); Named as an inventor on patents filed by Perthera, Inc. (as an employee); Named as an inventor on patents filed by Perthera, Inc. (as an employee); Named as an inventor on patents filed by Perthera, Inc. (as an employee)